1921
Volume 89, Issue 5
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

Abstract

Abstract.

Infections with bacteria producing extended-spectrum beta-lactamases (ESBLs) are increasing across Africa. This study reports on ESBL-producing as significant causes of infections and antibiotic resistance at Korle-Bu Teaching Hospital in Accra, Ghana. Of 300 isolates examined, 49.3% produced ESBLs. The prevalence of ESBLs was significantly high among isolates from neonates (28 of 43, 65.1%; relative risk = 1.62, 95% confidence interval = 1.33–2.13, = 0.002) and adult patients > 65 years of age (36 of 51, 70.5%; relative risk = 1.89, 95% confidence interval = 1.41–2.40, = 0.001). A marked increase in minimum inhibitory concentrations of ESBL-positive species was noticed compared with those for the other strains. Using these concentrations, we found that 26 (17%) ESBL producers were resistant to two or more antibiotics (aminoglycosides, fluoroquinolones, sulfonamide, and carbapenems) whereas 5 (3.2%) non–ESBL producers were multidrug resistant. Regular ESBL detection and evaluation of antibiotic resistance may help reduce the spread of ESBLs and antibiotic resistance in Ghana.

[open-access] This is an Open Access article distributed under the terms of the American Society of Tropical Medicine and Hygiene's Re-use License which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Loading

Article metrics loading...

/content/journals/10.4269/ajtmh.12-0642
2013-11-06
2017-11-18
Loading full text...

Full text loading...

/deliver/fulltext/14761645/89/5/960.html?itemId=/content/journals/10.4269/ajtmh.12-0642&mimeType=html&fmt=ahah

References

  1. Wilke MS, Lovering AL, Strynadka NCJ, , 2005. β-lactam antibiotic resistance: a current structural perspective. Curr Opin Microbiol 8: 525533.[Crossref]
  2. Jacoby GA, Munoz-Price LS, , 2005. The new β-lactamases. N Engl J Med 352: 380391.[Crossref]
  3. Thomson K, , 2013. Detection of gram-negative β-lactamase producing pathogens in the clinical lab. Curr Pharm Des 19: 250256.[Crossref]
  4. Liebana E, Carattoli A, Coque TM, Hasman H, Magiorakos AP, Mevius D, Peixe L, Poirel L, Schuepbach-Regula G, Torneke K, Torren-Edo J, Torres C, Threlfall J, , 2013. The public health risks of enterobacterial isolates producing extended-spectrum β-lactamases (ESBL) or AmpC β-lactamases in food and food-producing animals: an EU perspective of epidemiology, analytical methods, risk factors and control options. Clin Infect Dis 56: 10301037.[Crossref]
  5. Cantón R, Bryan J, , 2012. Global antimicrobial resistance: from surveillance to stewardship. Part 1: surveillance and risk factors for resistance. Expert Rev Anti Infect Ther 10: 12691271.[Crossref]
  6. Yi-Hui W, Po-Lin C, Yuan-Pin H, Wen-Chien K, , 2012. Risk factors and clinical impact of levofloxacin or cefazolin nonsusceptibility or ESBL production among uropathogens in adults with community-onset urinary tract infections. J Microbiol Immunol Infect 2012 Oct 11. pii:S1684-1182(12)00206-X, doi:1.1016/j.jmii2012.09.001 [Epub ahead of print].
  7. Essack SY, Hall LM, Pillay DG, McFadyen ML, Livermore DM, , 2001. Complexity and diversity of Klebsiella pneumoniae strains with extended-spectrum β-lactamases isolated in 1994 and 1996 at a teaching hospital in Durban, South Africa. Antimicrob Agents Chemother 45: 8895.[Crossref]
  8. Bell JM, Turnidge JD, Gales AC, Pfaller MA, Jones RN, , 2002. Prevalence of extended-spectrum β-lactamase (ESBL)-producing clinical isolates in the Asia-Pacific region and South Africa: regional results from SENTRY Antimicrobial Surveillance Program (1998 to 99). Diagn Microbiol Infect Dis 42: 193198.[Crossref]
  9. Tau NP, Smith AM, Sooka A, Keddy KH, , 2012. Molecular characterization of extended-spectrum β-lactamase-producing Shigella isolates from humans in South Africa, 2003–2009. J Med Microbiol 61: 162164.[Crossref]
  10. Bouchillon SK, Johnso BM, Hoban DJ, , 2004. Determining incidence of extended-spectrum β-lactamase-producing Enterobacteriaceae, vancomycin-resistant Enterococcus faecium and methicillin-resistant Staphylococcus aureus in 38 centres from 17 countries: the PEARLS study 2001 to 2002. Int J Antimicrob Agents 24: 119124.[Crossref]
  11. Khalaf NG, Eletreby MM, Hanson ND, , 2009. Characterization of CTX-M ESBLs in Enterobacter cloacae, Escherichia coli and Klebsiella pneumoniae clinical isolates from Cairo, Egypt. BMC Infect Dis 9: 8489.[Crossref]
  12. Ben-Hamouda T, Foulon T, Ben-Mahrez K, , 2004. Involvement of SHV-12 and SHV-2a encoding plasmids in outbreaks of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in a Tunisian neonatal ward. Microb Drug Resist 10: 132138.[Crossref]
  13. Aitmhand R, Soukri A, Moustaoui N, Amarouch H, Eimdaghri N, Sirot D, Benbachir M, , 2002. Plasmid-mediated TEM-3 extended-spectrum β-lactamase-production in Salmonella typhimurium in Casablanca. J Antimicrob Chemother 49: 169172.[Crossref]
  14. Blomberg B, Jureen R, Manji KP, Tamim BS, Mwakagile DS, Urassa WK, Fataki M, Msangi V, Tellevik MG, Maselle SY, Langeland N, , 2005. High rate of fatal cases of pediatric septicemia caused by gram-negative bacteria with extended-spectrum β-lactamases in Dar es Salaam, Tanzania. J Clin Microbiol 43: 745749.[Crossref]
  15. Aibinu I, Odugbemi T, Koenig W, Ghebremedhin B, , 2012. Sequence type ST131 and ST10 complex (ST617) predominant among CTX-M-15-producing Escherichia coli isolates from Nigeria. Clin Microbiol Infect 18: E49E51.[Crossref]
  16. Cowan ST, Steel KJ, Barrow GI, Feltham RK, , 2004. Characteristics of gram negative bacteria. , eds. Cowans and Steels Manual for Identification of Medical Bacteria. Third edition. London: Cambridge University Press, 94150.
  17. Clinical and Laboratory Standards Institute (CLSI), 2007. Performance standards for antimicrobial susceptibility testing, 17th informational supplement. M100-S17. Wayne, PA: The Institute.
  18. Clinical and Laboratory Standards Institute (CLSI), 2006. Methods for dilution antimicrobial susceptibility test for bacteria that grow aerobically, 7th edition. Approved standard. M7-A7. Wayne, PA: The Institute.
  19. Hoban D, Lascols C, Nicolle LE, Badal R, Bouchillon S, Hackel M, Hawser S, , 2012. Antimicrobial susceptibility of Enterobacteriaceae, including molecular characterization of extended-spectrum beta-lactamase-producing species, in urinary tract isolates from hospitalized patients in North America and Europe: results from the SMART study. Diagn Microbiol Infect Dis 74: 6264.[Crossref]
  20. European Centre for Disease Prevention and Control (ECDC), 2011. Antimicrobial resistance surveillance in Europe 2010. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net).
  21. Newman MJ, Frimpong E, Asamoah-Adu A, Sampane-Donkor E, Opintan JA, , 2011. Resistance to antimicrobial drugs in Ghana. Infect Drug Resist 4: 215220.
  22. Codjoe FS, Newman MJ, Enweronu-Laryea C, , 2009. Neonatal infections: is extended-spectrum β-lactamase-producing gram-negative bacilli part of the problem? Ghana J. of Allied Health Sciences 3: 1529.
http://instance.metastore.ingenta.com/content/journals/10.4269/ajtmh.12-0642
Loading
/content/journals/10.4269/ajtmh.12-0642
Loading

Data & Media loading...

  • Received : 18 Oct 2012
  • Accepted : 14 Apr 2013

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error